The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $112.11 million. The enterprise value is $176.89 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 75.75 million shares outstanding. The number of shares has increased by 1.76% in one year.
| Current Share Class | 75.75M |
| Shares Outstanding | 75.75M |
| Shares Change (YoY) | +1.76% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | 14.38% |
| Owned by Institutions (%) | 19.77% |
| Float | 46.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.24 |
| Forward PS | n/a |
| PB Ratio | 26.59 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.45 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.15, with a Debt / Equity ratio of 34.31.
| Current Ratio | 2.15 |
| Quick Ratio | 1.88 |
| Debt / Equity | 34.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.02 |
Financial Efficiency
Return on equity (ROE) is -213.36% and return on invested capital (ROIC) is -24.77%.
| Return on Equity (ROE) | -213.36% |
| Return on Assets (ROA) | -19.67% |
| Return on Invested Capital (ROIC) | -24.77% |
| Return on Capital Employed (ROCE) | -49.89% |
| Revenue Per Employee | $491,765 |
| Profits Per Employee | -$66,256 |
| Employee Count | 800 |
| Asset Turnover | 2.06 |
| Inventory Turnover | 28.62 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -5.13% in the last 52 weeks. The beta is 0.24, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -5.13% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 0.48 |
| Relative Strength Index (RSI) | 75.90 |
| Average Volume (20 Days) | 648,460 |
Short Selling Information
The latest short interest is 1.10 million, so 1.46% of the outstanding shares have been sold short.
| Short Interest | 1.10M |
| Short Previous Month | 1.07M |
| Short % of Shares Out | 1.46% |
| Short % of Float | 2.36% |
| Short Ratio (days to cover) | 2.10 |
Income Statement
In the last 12 months, TOI had revenue of $393.41 million and -$53.01 million in losses. Loss per share was -$0.71.
| Revenue | 393.41M |
| Gross Profit | 54.00M |
| Operating Income | -60.12M |
| Pretax Income | -57.85M |
| Net Income | -53.01M |
| EBITDA | -53.83M |
| EBIT | -60.12M |
| Loss Per Share | -$0.71 |
Full Income StatementBalance Sheet
The company has $49.67 million in cash and $123.15 million in debt, giving a net cash position of -$73.48 million or -$0.97 per share.
| Cash & Cash Equivalents | 49.67M |
| Total Debt | 123.15M |
| Net Cash | -73.48M |
| Net Cash Per Share | -$0.97 |
| Equity (Book Value) | 3.59M |
| Book Value Per Share | 0.05 |
| Working Capital | 60.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$26.54 million and capital expenditures -$3.79 million, giving a free cash flow of -$30.33 million.
| Operating Cash Flow | -26.54M |
| Capital Expenditures | -3.79M |
| Free Cash Flow | -30.33M |
| FCF Per Share | -$0.40 |
Full Cash Flow StatementMargins
Gross margin is 13.73%, with operating and profit margins of -15.28% and -16.44%.
| Gross Margin | 13.73% |
| Operating Margin | -15.28% |
| Pretax Margin | -16.44% |
| Profit Margin | -16.44% |
| EBITDA Margin | -13.68% |
| EBIT Margin | -15.28% |
| FCF Margin | n/a |